As per the report titled ‘GLOBAL SEQUENCING REAGENTS MARKET 2021-2028’, available with MarketStudyReport, global sequencing reagents market is projected to register a year-over-year growth rate of 12.83% over the forecast period 2021-2028.

According to the findings of the report, global sequencing reagents market is mainly driven by continuous research in genomics due to rising prevalence of chronic diseases, technological advancements, and investments by manufacturers and governments in this field.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4345875/

Escalating demand for third-generation sequencing solutions is anticipated to present new opportunities in the upcoming years. On the contrary, social and ethical concerns regarding data privacy and dearth of skilled workforce in developing regions may hinder progress.

The market, on the basis of application, is split into oncology, clinical investigation, agri genomics and forensics, reproductive health, and others. In terms of reagent type, the industry is split into sequencing kits, library kits, control kits, template kits, and others.

Moving to the technology landscape, the bifurcation comprises next-generation sequencing, third-generation sequencing, and Sanger sequencing. Considering industry verticals, the market is segmented into research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

From a regional perspective, worldwide sequencing reagents industry spans North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Speaking of country-level assessment, the United States, Canada, France, Germany, United Kingdom, Russia, Italy, Spain, India, China, Japan, South Korea, Australia & New Zealand, ASEAN Countries, Mexico, Brazil, Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Turkey are the major countries defining the size and scope of the market.

Experts cite that Asia Pacific market is anticipated to expand at an astounding rate over the assessment period. Inflowing government investments across major economies, and rise in R&D activities concerning genomics favoring the regional market growth.

Speaking of the competitive landscape, major players influencing global sequencing reagents market are TriLink BioTechnologies Inc., Thermo Fisher Scientific Inc., Takara Bio Inc., Qiagen N.V., PerkinElmer Inc., Pacific Biosciences of California Inc., Merck KGaA, LGC Biosearch Technologies, Illumina Inc., Fluidigm Corp., F Hoffman La Roche, Bio Rad Laboratories Inc., BGI Group, Asuragen Inc., and Agilent Technologies Inc.